This test is most useful if any of these apply to you.
Nearly everyone who gets tested carries measurable amounts of this chemical, and the people with the highest levels tend to have more heart disease, diabetes, and obesity. This test tells you where your recent exposure sits.
It is a research-grade measurement, not a diagnosis, and a single reading bounces around a lot from day to day. But getting a baseline and watching your trend gives you real data on whether the changes you make at home are actually lowering what reaches your body.
BPA (bisphenol A) is a synthetic chemical used to make polycarbonate plastics and the epoxy resins that line food cans. Your body does not make it. You take it in mostly from food and drink that touched these materials, with smaller amounts from handling thermal-paper receipts and household dust.
Once swallowed, BPA is absorbed quickly and then rapidly attached to a sugar molecule in your gut and liver, a change that makes it easier to flush out in urine. Because this happens fast, urine is the standard way to measure exposure, and the number reflects what got into you over roughly the past day rather than a lifetime of buildup.
This is why the test is best understood as an exposure marker. A high result means more of the chemical recently reached your bloodstream. It does not, by itself, tell you that any specific organ has been damaged, but higher exposure tracks with a range of health risks described below.
The most consistent human signal links higher urinary BPA to cardiovascular disease. In a national US survey of about 9,000 adults tracked for deaths over time, people with higher urinary BPA had a higher risk of dying from heart and blood-vessel disease, and the association was more pronounced in women. A separate national analysis found that higher levels came with roughly 13% greater odds of having cardiovascular disease, a figure that held up in a pooled meta-analysis.
Earlier survey data pointed the same direction, tying higher urinary BPA to more stroke, heart failure, and angina, again with a stronger pattern in men in that particular dataset. In one older study of about 1,455 US adults, each step up in BPA came with roughly 39% higher odds of a heart disease diagnosis.
What this means for you: these are observational links, not proof that lowering BPA prevents a heart attack. But if you already carry cardiovascular risk factors, a high exposure reading is one more reason to reduce the sources you can control.
Higher BPA has been repeatedly associated with diabetes. In the same survey of about 1,455 adults, higher levels came with roughly 39% higher odds of diabetes for each step up in BPA. In a smaller study of 60 people with type 2 diabetes, those with higher blood BPA had poorer blood-sugar control, more insulin resistance, more signs of cells aging early, and shorter protective caps on their chromosomes.
What this means for you: if your blood sugar sits in the borderline range, pairing this test with a fasting insulin or long-term blood-sugar marker gives a fuller picture of your metabolic risk than either alone.
Across US and Korean adults, people in the highest third of bisphenol exposure had about 58% higher odds of obesity in the US group and about 41% higher odds in the Korean group, along with higher triglycerides and lower protective HDL cholesterol. A pooled analysis of many studies found that each small rise in BPA was linked to roughly 11% higher odds of obesity, regardless of the type of obesity, sex, or age.
A separate meta-analysis tied higher BPA specifically to abdominal obesity, the fat pattern most closely linked to metabolic disease. BPA also tracks with higher uric acid and a greater chance of gout in national US data.
Higher BPA has been linked to abnormal liver enzymes in population data, with roughly 29% higher odds of an elevated GGT (gamma-glutamyl transferase, a liver enzyme) and about 48% higher odds of an elevated ALP (alkaline phosphatase, another liver enzyme) at higher exposure. Reviews connect higher exposure to non-alcoholic fatty liver disease, where fat and inflammation build up in the liver.
Inflammation is a recurring theme. A study of 200 people found that BPA amplified the body-wide inflammatory response in those with Crohn's disease and a leaky gut barrier, and broader reviews consistently link higher bisphenol exposure to higher inflammatory markers in the blood.
BPA behaves like a weak estrogen and can blunt male hormone signals, which is why it is classed as an endocrine disruptor (a chemical that interferes with the body's hormone systems). In women, higher levels are reported alongside polycystic ovary syndrome, diminished ovarian reserve, and pregnancy complications; in men, reviews describe links to poorer semen quality.
The evidence here is more mixed than for heart and metabolic disease. One meta-analysis found no significant link between BPA in pregnancy and gestational diabetes, so the reproductive picture is still being worked out rather than settled.
In a large Spanish arm of a European cancer study, men with detectable serum BPA had a higher risk of prostate cancer than those below the detection limit. Breast cancer patients have shown higher BPA in both urine and breast fat tissue than women without the disease, and in overweight or obese people with thyroid nodules, higher BPA was associated with a greater chance the nodules were malignant.
One large survey found a U-shaped pattern for cancer death, meaning risk was higher at both very low and higher BPA levels, with the lowest measured exposure group showing more cancer mortality. That looks like it contradicts the idea that more BPA is worse.
Here is how both findings fit together. Urinary BPA is a noisy snapshot of recent exposure, not a clean lifelong dose, and people who are already ill often eat less and differently, which can push their measured BPA down for reasons that have nothing to do with the chemical protecting them. Treat this marker as an exposure signal to interpret alongside your overall health, not as a number where lower is automatically safer at the very bottom of the range.
Lead with the biggest caveat: a single BPA measurement is unreliable as a picture of your usual exposure. Because the chemical clears in about six hours after you eat, your level swings widely across the day and from one day to the next. In repeated-sampling studies, the agreement between a person's samples was poor, with reproducibility scores often around 0.1 to 0.2, where 1.0 would mean perfect consistency.
Two other factors matter. Levels follow a daily rhythm, tending to run higher in the morning and evening and lower in the afternoon, so the time of day you collect changes the result. And how watered-down your urine is shifts the raw number, which is why labs adjust for creatinine (a waste product used to correct for urine dilution).
One quirk to know: exposure through the skin, such as from handling receipts, lingers far longer than exposure from food. After skin contact the chemical can stay detectable in urine for several days, versus about a day after a meal, so a recent receipt-heavy shift at work can leave a longer footprint than a single packaged lunch.
Because any one sample is noisy, the value of this test comes from repetition, not from a single result. Modeling suggests it would take around five samples to reach even fair consistency for an individual, so think of your first reading as a rough anchor rather than a verdict.
A practical approach: collect a baseline, ideally at a consistent time of day such as a first-morning sample, then retest after 6 to 12 weeks if you are actively changing your habits, and at least annually thereafter. When you compare readings, a real downward trend across several samples means far more than the difference between any two single tests.
Serial testing is also the only honest way to know whether a change you made is working. If you swap out packaging and food-storage habits, a drop confirmed across repeated samples tells you the effort actually reached your bloodstream, which a one-time before-and-after cannot reliably show.
If your level comes back high, the first move is to repeat it rather than react to one number, since variability alone can explain a surprising reading. Note what you ate and whether you handled receipts in the day before the sample, and collect the follow-up at the same time of day.
If a high level holds up across samples and you also carry metabolic risk, this is a reason to look at the connected numbers together: a fasting insulin or long-term blood-sugar marker, an inflammation marker, and a standard lipid panel. A pattern of high exposure alongside rising insulin resistance or inflammation is more actionable than any single value, and is worth raising with a clinician who understands environmental exposures if you want a structured workup.
Be skeptical of any product or clinic offering a BPA detox or chelation. The evidence points to reducing your incoming exposure, not to any treatment that scrubs the chemical out faster.
Evidence-backed interventions that affect your BPA level
Bisphenol A is best interpreted alongside these tests.
Bisphenol A is included in these pre-built panels.